These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 28729203)
1. Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution method. Maloney S; Engler C; Norton R J Glob Antimicrob Resist; 2017 Sep; 10():291-294. PubMed ID: 28729203 [TBL] [Abstract][Full Text] [Related]
2. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia. Crowe A; McMahon N; Currie BJ; Baird RW Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662 [TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam. Nhung PH; Van VH; Anh NQ; Phuong DM J Glob Antimicrob Resist; 2019 Sep; 18():34-36. PubMed ID: 30685463 [TBL] [Abstract][Full Text] [Related]
4. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Jenney AW; Lum G; Fisher DA; Currie BJ Int J Antimicrob Agents; 2001 Feb; 17(2):109-13. PubMed ID: 11165114 [TBL] [Abstract][Full Text] [Related]
5. Burkholderia pseudomallei: in vitro susceptibility to some new and old antimicrobials. Karunakaran R; Puthucheary SD Scand J Infect Dis; 2007; 39(10):858-61. PubMed ID: 17852912 [TBL] [Abstract][Full Text] [Related]
6. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis. Castelo-Branco DS; Riello GB; Vasconcelos DC; Guedes GM; Serpa R; Bandeira TJ; Monteiro AJ; Cordeiro RA; Rocha MF; Sidrim JJ; Brilhante RS J Appl Microbiol; 2016 Mar; 120(3):600-6. PubMed ID: 26669506 [TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of Burkholderia pseudomallei isolates from Thai patients to ceftolozane/tazobactam and ceftazidime/avibactam. Sribenjalux W; Wonglakorn L; Meesing A J Glob Antimicrob Resist; 2022 Mar; 28():8-11. PubMed ID: 34922057 [TBL] [Abstract][Full Text] [Related]
8. Burkholderia pseudomallei multi-centre study to establish EUCAST MIC and zone diameter distributions and epidemiological cut-off values. Karatuna O; Dance DAB; Matuschek E; Åhman J; Turner P; Hopkins J; Amornchai P; Wuthiekanun V; Cusack TP; Baird R; Hennessy J; Norton R; Armstrong M; Zange S; Zoeller L; Wahab T; Jacob D; Grunow R; Kahlmeter G Clin Microbiol Infect; 2020 Jul; ():. PubMed ID: 32653660 [TBL] [Abstract][Full Text] [Related]
9. The antibiotics of choice for the treatment of melioidosis in Indian set up. Shaw T; Tellapragada C; Eshwara VK; Bhat HV; Mukhopadhyay C Indian J Med Microbiol; 2016; 34(3):353-4. PubMed ID: 27514960 [TBL] [Abstract][Full Text] [Related]
10. Assessing the colony morphotypes and antibiotic susceptibility profile of Malaysian clinical Burkholderia pseudomallei to support the use of EUCAST disk diffusion breakpoints to determine antibiotic resistance. Hii SYF; Zaiful Bahrina NN; Mohd Zaidi MN; Hashim R; Ahmad N Eur J Clin Microbiol Infect Dis; 2024 Feb; 43(2):373-378. PubMed ID: 37999783 [TBL] [Abstract][Full Text] [Related]
11. Comparison between the antimicrobial susceptibility of Burkholderia pseudomallei to trimethoprim-sulfamethoxazole by standard disk diffusion method and by minimal inhibitory concentration determination. Lumbiganon P; Tattawasatra U; Chetchotisakd P; Wongratanacheewin S; Thinkhamrop B J Med Assoc Thai; 2000 Aug; 83(8):856-60. PubMed ID: 10998837 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility pattern of clinical isolates of Burkholderia pseudomallei in Bangladesh. Dutta S; Haq S; Hasan MR; Haq JA BMC Res Notes; 2017 Jul; 10(1):299. PubMed ID: 28728591 [TBL] [Abstract][Full Text] [Related]
13. Raising the Stakes: Loss of Efflux Pump Regulation Decreases Meropenem Susceptibility in Burkholderia pseudomallei. Sarovich DS; Webb JR; Pitman MC; Viberg LT; Mayo M; Baird RW; Robson JM; Currie BJ; Price EP Clin Infect Dis; 2018 Jul; 67(2):243-250. PubMed ID: 29394337 [TBL] [Abstract][Full Text] [Related]
14. Correlation Between Etest and Reference Broth Microdilution for Antimicrobial Susceptibility Testing of Lonsway DR; Elrod MG; Kendrick N; Tiller R; Sullivan MM; Edwards JR; Blaney DD; Karlsson M Microb Drug Resist; 2020 Apr; 26(4):311-318. PubMed ID: 31596673 [TBL] [Abstract][Full Text] [Related]
15. In vitro activities of amoxicillin-clavulanate, doxycycline, ceftazidime, imipenem, and trimethoprim-sulfamethoxazole against biofilm of Brazilian strains of Burkholderia pseudomallei. Bandeira Tde J; Moreira CA; Brilhante RS; Castelo-Branco Dde S; Neto MP; Cordeiro Rde A; Rodrigues Tde J; Rocha MF; Sidrim JJ Antimicrob Agents Chemother; 2013 Nov; 57(11):5771-3. PubMed ID: 24002089 [TBL] [Abstract][Full Text] [Related]
16. A comparison of antibiotic susceptibility testing methods for cotrimoxazole with Burkholderia pseudomallei. Piliouras P; Ulett GC; Ashhurst-Smith C; Hirst RG; Norton RE Int J Antimicrob Agents; 2002 May; 19(5):427-9. PubMed ID: 12007851 [TBL] [Abstract][Full Text] [Related]